☰

Nicholas Hughes - Publications

Affiliations: 
2008-2011 Radiology Stanford University, Palo Alto, CA 
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Tang R, Shuldiner EG, Kelly M, Murray CW, Hebert JD, Andrejka L, Tsai MK, Hughes NW, Parker MI, Cai H, Li YC, Wahl GM, Dunbrack RL, Jackson PK, Petrov DA, et al. Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growth. Nature Cell Biology. PMID 36635501 DOI: 10.1038/s41556-022-01049-w  0.374
2012 Hughes N, Mehta S, Winchester L, Han C, Buffa F, Adams R, Harris A. Abstract P4-01-01: Integrating dynamic magnetic resonance imaging and gene expression profiling reveals novel therapeutic targets in locally advanced breast cancer. Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P4-01-01  0.408
2012 Mehta S, Hughes N, Adams R, Li S, Han C, Kaur K, Taylor N, Padhani A, Makris A, Buffa F, Harris A. Abstract P1-06-01: Upregulation of metabolism as a potential resistance mechanism to bevacizumab in primary breast cancer Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P1-06-01  0.399
2011 Mehta S, Hughes NP, Buffa FM, Li SP, Adams RF, Adwani A, Taylor NJ, Levitt NC, Padhani AR, Makris A, Harris AL. Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles. Journal of the National Cancer Institute. Monographs. 2011: 71-4. PMID 22043045 DOI: 10.1093/jncimonographs/lgr027  0.365
2011 Tseng JR, Stuart D, Aardalen K, Kaplan A, Aziz N, Hughes NP, Gambhir SS. Use of DNA microarray and small animal positron emission tomography in preclinical drug evaluation of RAF265, a novel B-Raf/VEGFR-2 inhibitor. Neoplasia (New York, N.Y.). 13: 266-75. PMID 21390189 DOI: 10.1593/Neo.101466  0.392
2010 Mehta S, Buffa F, Li S, Hughes N, Adams R, Adwani A, Taylor N, Levitt N, Padhani A, Makris A, Harris A. Abstract P2-09-28: Integrated Gene Expression and MRI Analysis To Assess Early Therapeutic Response to Bevacizumab in Primary Breast Cancer Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P2-09-28  0.373
2010 Hughes N, Mehta S, Li S, Taylor J, Adwani A, Buffa F, Levitt N, Makris A, Adams R, Harris A, Padhani A. Abstract P2-02-07: Predicting Response to Bevacizumab Therapy in Primary Breast Cancer Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P2-02-07  0.356
Show low-probability matches.